Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Low testosterone levels may contribute to female pattern hair loss in men.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

DPCP can help regrow hair in some people with severe alopecia.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

DCP in isopropanol is better tolerated for treating alopecia areata.